Climaco John M — SEC insider filings

SEC reporting owner CIK 1546797. 17 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2021-02-09 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CNS Pharmaceuticals, Inc. (CNSP)Chief Executive Officer, Director113 legs · 184,416 sh · $65,353—12
Moleculin Biotech, Inc. (MBRX)Director6——7

Insider filings — Climaco John M

FiledFormIssuerReported transactionsSource
2026-11-194Moleculin Biotech, Inc. (MBRX)Grant/award (A): 4,000 (derivative)EDGAR
2025-11-194CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 9,761 (derivative) @ $0EDGAR
2025-11-144Moleculin Biotech, Inc. (MBRX)Grant/award (A): 150,000 (derivative)EDGAR
2024-11-064Moleculin Biotech, Inc. (MBRX)Grant/award (A): 10,000 (derivative)EDGAR
2024-04-104CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 83,000 (derivative) · Grant/award (A): 83,000 (derivative)EDGAR
2024-02-064CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 166,666 @ $0.30 · Grant/award (A): 166,666 (derivative) · Grant/award (A): 166,666 (derivative)EDGAR
2023-08-164CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 2,750 @ $1.80EDGAR
2023-05-264Moleculin Biotech, Inc. (MBRX)Grant/award (A): 15,000 (derivative)EDGAR
2023-05-014CNS Pharmaceuticals, Inc. (CNSP)Option exercise (M): 1,250 · Option exercise (M): 1,250 (derivative)EDGAR
2023-04-144CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 15,000 @ $0.69EDGAR
2023-03-314CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 16,467 (derivative)EDGAR
2022-06-224Moleculin Biotech, Inc. (MBRX)Grant/award (A): 23,333 (derivative) · Grant/award (A): 15,000 (derivative)EDGAR
2022-04-294CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 600,000 (derivative)EDGAR
2022-03-084CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 35,000 @ $0.28EDGAR
2021-11-184CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 5,000 @ $1.28EDGAR
2021-06-094Moleculin Biotech, Inc. (MBRX)Grant/award (A): 10,000 (derivative)EDGAR
2021-02-094CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 310,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1546797 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs